TIKUN RESEARCH CONTRIBUTORS
Tikun Olam Israel
Dr. Raphael Mechoulam
Known as the ‘godfather of cannabis’ Dr. Mechoulam was the first to isolate THC and has achieved many breakthroughs in cannabis research. He mentored our founder, Tzachl Cohen, and has co-authored many of our clinical studies.
Dr. Lihi Bar-Lev Schielder
Lihi received her MA in Psychobiology and is earning her PhD in medicine at Ben Gurion University in Israel. As the Founder and Director of our research department, she oversees medical writing, patient data collection, and clinical trials.
Dr. Victor Novack
Dr. Novack is a clinical epidemiologist, studying disease and the way it spreads, and his work has been published in more than 200 papers. As part of the research team at Tikun Olam, he focuses on designing and implementing clinical trials
Dr. Ruth Gallily
A pioneer in cannabis research, Dr. Ruth Gallily is a professor of immunology who has been studying the anti-inflammatory effects of CBD for the past few decades. Her research with Tikun Olam is deeply rooted in the medical applications of the cannabis plant.
Dr. Timna Naftali
Gastroenterologist Dr. Naftali was the first person to research the effects of cannabis on inflammatory bowel disease (IBD). With Tikun Olam, she continues to research cannabis for the treatment of colitis, Crohn’s disease, and other gastrointestinal disorders.
Dr. Zvi Bentwich
Dr. Berawich is a physician, clinical immunologist, and world-renowned expert on AIDS research. with vast clinical, educational, and biomedical research experience, he joined the team in 2015 as Chief Scientist, where he leads several clinical trials.